Conatus

YTD

ALL

Why Robinhood?

You can watch Conatus and buy or sell other stocks, ETFs, and their options commission-free!

About CNAT

Conatus Pharmaceuticals, Inc. is a biotechnology company that focuses on the development and commercialization of novel medicines to treat chronic diseases. The firm engages in developing emricasan, an orally active pan-caspase inhibitor, for the treatment of patients with chronic liver disease and is designed to reduce the activities of human caspases.

CEO

Steven J. Mento, PhD

CEOSteven J. Mento, PhD

Employees

—

Employees—

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

2005

Founded2005

Employees

—

Employees—

CNAT Key Statistics

Market cap

115.30K

Market cap115.30K

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

436.00

Average volume436.00

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$0.3514

52 Week high$0.3514

52 Week low

$0.02

52 Week low$0.02